Format

Send to

Choose Destination
Curr Opin Genet Dev. 2003 Feb;13(1):77-83.

Tumor suppression by Ink4a-Arf: progress and puzzles.

Author information

1
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA. lowe@cshl.org

Abstract

The two products of the Ink4a-Arf locus, p16(Ink4a) and p19(Arf) (p14(ARF) in humans), are potent tumor suppressors that regulate the activities of the retinoblastoma protein and the p53 transcription factor. These proteins form part of a signaling network that is disrupted in most, if not all, cancer cells. The Ink4a-Arf locus responds to stress signals, limiting cell proliferation and modulating oncogene-induced apoptosis. Recent evidence emerging from mouse tumor models distinguishes the activities of p16(Ink4a) and p19(Arf) in regulating tumor onset and identifies differences in their responsiveness to drugs.

PMID:
12573439
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center